ARCHIVES

Funding Opportunities.

This article is from The Cancer Letter archive.

Vol. 28 No. 21 | May 24, 2002

Download PDF Visit The Full Archive

Related Articles

In Brief: Mayo Director Kovach Moves To City Of Hope; Seattle Institutions Win Gene Therapy

May 20, 1994

In Brief: Best Guess On NCI Director: Brown First Choice, Benacerraf Second; FDa On Saccharin

April 22, 1977

Doxepin Rinse Reduces Pain In Radiation Therapy Patients

November 30, 2012

FDA Advisors Recommend Approval Of Topotecan for Ovarian Cancer

April 26, 1996

Are Cancer Drugs Getting Better? FDA’s Richard Pazdur Says “Yes”

February 14, 2014

Obey Says NCI “Must Do Better,” Response Dispute GAO Conclusion

August 8, 1980